Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.17/Share

February 26, 2020 5:07 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.17), versus ($0.14) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

... More